| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,078 |
11,115 |
$1.18M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,827 |
9,218 |
$662K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,868 |
10,153 |
$528K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13,038 |
11,963 |
$506K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,840 |
3,597 |
$366K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,137 |
2,986 |
$308K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,843 |
2,613 |
$294K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,628 |
1,558 |
$233K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,962 |
1,878 |
$184K |
| 94060 |
|
2,282 |
2,208 |
$109K |
| 95012 |
|
4,282 |
4,039 |
$69K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,498 |
1,417 |
$55K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,275 |
4,036 |
$45K |
| 94010 |
|
1,823 |
1,673 |
$45K |
| 96127 |
|
4,397 |
4,029 |
$34K |
| 99188 |
|
1,920 |
1,893 |
$34K |
| 92567 |
|
1,809 |
1,673 |
$32K |
| 99401 |
|
6,807 |
6,364 |
$31K |
| 99429 |
|
3,222 |
1,638 |
$25K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,543 |
1,477 |
$23K |
| 99051 |
|
1,265 |
1,179 |
$22K |
| 85018 |
|
7,893 |
7,374 |
$21K |
| 81002 |
|
7,275 |
6,787 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
560 |
534 |
$16K |
| D1206 |
Topical application of fluoride varnish |
723 |
708 |
$13K |
| 92551 |
|
4,632 |
4,241 |
$12K |
| 96160 |
|
4,258 |
4,042 |
$9K |
| 99173 |
|
4,969 |
4,611 |
$9K |
| 99383 |
|
75 |
74 |
$9K |
| 94761 |
|
678 |
640 |
$7K |
| 99381 |
|
81 |
70 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
55 |
55 |
$6K |
| 96161 |
|
2,012 |
1,838 |
$6K |
| 99384 |
|
41 |
40 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,300 |
1,232 |
$5K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
3,926 |
3,657 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
295 |
271 |
$5K |
| 97802 |
|
5,480 |
5,187 |
$4K |
| A7015 |
Aerosol mask, used with dme nebulizer |
2,733 |
2,640 |
$4K |
| 80061 |
Lipid panel |
284 |
227 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
32 |
29 |
$3K |
| 0071A |
|
76 |
70 |
$3K |
| 87807 |
|
183 |
172 |
$3K |
| 94664 |
|
140 |
136 |
$2K |
| 0072A |
|
54 |
51 |
$2K |
| 90670 |
|
1,191 |
1,145 |
$2K |
| 90620 |
|
255 |
225 |
$2K |
| 0001A |
|
45 |
43 |
$2K |
| 90480 |
|
48 |
40 |
$2K |
| 0002A |
|
35 |
35 |
$1K |
| 90686 |
|
3,236 |
3,030 |
$1K |
| 90651 |
|
871 |
810 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
32 |
32 |
$1K |
| 94760 |
|
1,146 |
1,079 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
862 |
805 |
$793.95 |
| A4616 |
Tubing (oxygen), per foot |
2,349 |
2,262 |
$420.31 |
| 90734 |
|
579 |
540 |
$283.73 |
| 90671 |
|
91 |
83 |
$246.20 |
| 90648 |
|
1,182 |
1,141 |
$222.72 |
| 90713 |
|
564 |
545 |
$122.25 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
2,202 |
2,111 |
$99.60 |
| 91300 |
|
93 |
83 |
$82.02 |
| 90700 |
|
1,245 |
1,205 |
$68.85 |
| J7510 |
Prednisolone oral, per 5 mg |
29 |
29 |
$8.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
17 |
16 |
$4.50 |
| 90744 |
|
210 |
192 |
$0.00 |
| 90680 |
|
393 |
379 |
$0.00 |
| 91307 |
|
135 |
121 |
$0.00 |
| 90696 |
|
39 |
39 |
$0.00 |
| 90716 |
|
361 |
346 |
$0.00 |
| 90677 |
|
28 |
27 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
13 |
13 |
$0.00 |
| 90723 |
|
18 |
15 |
$0.00 |
| 90661 |
|
15 |
14 |
$0.00 |
| 90707 |
|
374 |
359 |
$0.00 |
| 5250F |
|
922 |
884 |
$0.00 |
| 90633 |
|
425 |
405 |
$0.00 |
| 90715 |
|
114 |
106 |
$0.00 |
| 90685 |
|
300 |
288 |
$0.00 |
| 99442 |
|
37 |
26 |
$0.00 |